Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 3
2007 3
2008 1
2011 1
2013 1
2017 1
2018 1
2019 3
2020 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Adherence to the National Guidelines for Follow-Up Protocol in Subjects with Type 2 Diabetes Mellitus in Greece: The GLANCE Study.
Papanas N, Elisaf M, Kotsa K, Melidonis A, Bousboulas S, Bargiota A, Pagkalos E, Doupis J, Ioannidis I, Avramidis I, Pappas AC, Karousos G, Arvaniti E, Bristianou M, Pietri K, Karamousouli E, Voss B, Migdalis I, Tentolouris N. Papanas N, et al. Among authors: pagkalos e. Diabetes Ther. 2020 Dec;11(12):2887-2908. doi: 10.1007/s13300-020-00935-6. Epub 2020 Oct 3. Diabetes Ther. 2020. PMID: 33011924 Free PMC article.
Real-World Adequacy of Glycaemic Control in Treatment-Naïve Greek Patients with Type 2 Diabetes Mellitus Initiating Treatment with Metformin Monotherapy at the Maximum Tolerated Dose: The Reload Study.
Tsimihodimos V, Bargiota A, Pagkalos EM, Manes C, Papas A, Karamousouli E, Voss B, Elisaf MS. Tsimihodimos V, et al. Among authors: pagkalos em. Exp Clin Endocrinol Diabetes. 2020 Apr;128(4):224-230. doi: 10.1055/a-0824-6607. Epub 2019 Jan 22. Exp Clin Endocrinol Diabetes. 2020. PMID: 30669167
Influence of Supervised Disease Understanding and Diabetes Self-Management on Adherence to Oral Glucose-Lowering Treatment in Patients with Type 2 Diabetes.
Doupis J, Alexandrides T, Elisaf M, Melidonis A, Bousboulas S, Thanopoulou A, Pagkalos EM, Avramidis I, Pappas A, Arvaniti E, Karamousouli E, Voss B, Tentolouris N. Doupis J, et al. Among authors: pagkalos em. Diabetes Ther. 2019 Aug;10(4):1407-1422. doi: 10.1007/s13300-019-0648-9. Epub 2019 Jun 20. Diabetes Ther. 2019. PMID: 31222592 Free PMC article.
Effectiveness and tolerability of second-line therapy with vildagliptin vs. other oral agents in type 2 diabetes: a real-life worldwide observational study (EDGE).
Mathieu C, Barnett AH, Brath H, Conget I, de Castro JJ, Göke R, Márquez Rodriguez E, Nilsson PM, Pagkalos E, Penfornis A, Schaper NC, Wangnoo SK, Kothny W, Bader G. Mathieu C, et al. Among authors: pagkalos e. Int J Clin Pract. 2013 Oct;67(10):947-56. doi: 10.1111/ijcp.12252. Epub 2013 Aug 21. Int J Clin Pract. 2013. PMID: 23961850 Free PMC article.
Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection.
Lavillette D, Morice Y, Germanidis G, Donot P, Soulier A, Pagkalos E, Sakellariou G, Intrator L, Bartosch B, Pawlotsky JM, Cosset FL. Lavillette D, et al. Among authors: pagkalos e. J Virol. 2005 May;79(10):6023-34. doi: 10.1128/JVI.79.10.6023-6034.2005. J Virol. 2005. PMID: 15857988 Free PMC article.
15 results